Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 
Category: Rheumatology | Monthly Briefing

Back to Journal Articles

April 2011 Briefing - Rheumatology

Last Updated: May 02, 2011.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for April 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Wegener's Granulomatosis Tied to Higher Solid Tumor Risk

THURSDAY, April 28 (HealthDay News) -- The increased risk of solid malignancies seen in patients with Wegener's granulomatosis treated with etanercept during the Wegener's Granulomatosis Etanercept Trial (WGET) remained increased during long-term post-trial follow-up, according to a study published online April 11 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Cervical Instabilities Progress in Rheumatoid Arthritis

TUESDAY, April 26 (HealthDay News) -- In patients with rheumatoid arthritis (RA), vertical subluxation (VS) and subaxial subluxation (SAS) increase over time, especially in patients with pre-existing VS, SAS, and/or mutilating changes, according to a study published in the April 15 issue of Spine.

Abstract
Full Text (subscription or payment may be required)

Ultrasound Shows Pathology in Joints Despite Remission

WEDNESDAY, April 20 (HealthDay News) -- Children with juvenile idiopathic arthritis (JIA) in clinical remission may continue to show signs of pathology on joint ultrasounds, which may be indicative of ongoing inflammation, according to a study published online April 11 in Arthritis Care & Research.

Abstract
Full text (subscription or payment may be required)

Physical Activity Guidelines May Improve Survival

WEDNESDAY, April 20 (HealthDay News) -- Meeting the recommendations set out in the federal 2008 Physical Activity Guidelines for Americans is associated with reduced all-cause mortality in U.S. adults, according to a study published online April 5 in the American Journal of Preventive Medicine.

Full Text

Adalimumab Maintains Remission of Childhood Uveitis

MONDAY, April 18 (HealthDay News) -- Children with noninfectious childhood uveitis are more likely to remain in remission when treated with adalimumab compared to infliximab, according to a study published in the April issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Self-Rated Health Predicts Outcomes of Joint Replacement

THURSDAY, April 14 (HealthDay News) -- Mental well-being and self-rated health (SRH) predict outcomes of total joint replacements, more than patients' prior physical health, according to a study published online March 18 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Adalimumab Antibodies Linked to Treatment Failure

WEDNESDAY, April 13 (HealthDay News) -- Development of antibodies against adalimumab may have an effect on treatment discontinuation, disease activity, and remission in patients with rheumatoid arthritis (RA), according to a study published April 13 in an infectious disease and immunology themed issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Diabetes and Disease Activity Predict Depression in Lupus

TUESDAY, April 12 (HealthDay News) -- Diabetes mellitus and systemic lupus erythematosus (SLE)-related disease activity appear to increase the likelihood of developing depression in SLE, according to a study published in the April issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Rheumatoid Arthritis Treatment May Reduce Diabetes Risk

MONDAY, April 11 (HealthDay News) -- Extended use of tumor necrosis factor α (TNFα) antagonists in patients with rheumatoid arthritis (RA) may reduce the risk of developing insulin resistance (IR), according to a review published in the April issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

First U.S. Test to Diagnose Dengue Fever Approved

MONDAY, April 11 (HealthDay News) -- The first test to help diagnose people with symptoms of the mosquito-borne virus dengue fever has been approved by the U.S. Food and Drug Administration.

dengue fever

Imatinib Reduces Cutaneous Systemic Sclerosis Symptoms

MONDAY, April 11 (HealthDay News) -- Imatinib mesylate is well tolerated by patients with diffuse cutaneous systemic sclerosis (dcSSc) with improvement in skin thickening and forced vital capacity (FVC), according to a study published online March 11 in the Annals of the Rheumatic Diseases.

Abstract
Full Text

'Global Trigger Tool' Identifies 10 Times More Errors

THURSDAY, April 7 (HealthDay News) -- Use of the new Global Trigger Tool, developed by the Institute for Healthcare Improvement, detects at least 10 times more adverse events than other methods currently in use, according to a study published in the April issue of Health Affairs.

Abstract
Full Text (subscription or payment may be required)

Guidelines for Juvenile Arthritis Treatment Published

THURSDAY, April 7 (HealthDay News) -- New guidelines for the treatment of children with juvenile idiopathic arthritis (JIA) have been developed by the American College of Rheumatology; the guidelines are based on the best available scientific evidence and expert opinion and have been published in the April issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Rituximab Does Not Improve Safety Profile of RA Treatment

MONDAY, April 4 (HealthDay News) -- Combining rituximab with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with rheumatoid arthritis (RA) does not offer any safety improvement, according to a study published in the March issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Patients, Doctors Agree OA Care Needs Improvement

MONDAY, April 4 (HealthDay News) -- Patients with osteoarthritis (OA) and health professionals involved in treatment agree about health care provision for OA, stressing the need for an OA specialist in primary care and better information at or soon after diagnosis, according to a study published online March 8 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Autoimmune Diseases Number Two Cause of Chronic Illness

FRIDAY, April 1 (HealthDay News) -- Autoimmune diseases are the second leading cause of chronic illness in the United States and constitute a major direct and indirect economic burden to the U.S. health care system, according to a report released by the American Autoimmune Related Diseases Association (AARDA) on March 22 at a congressional briefing.

Full Text

Cell Phone Proximity to Hip Tied to Bone Mineralization

FRIDAY, April 1 (HealthDay News) -- Men who carry their cell phone next to their hip may have reduced bone mineral content (BMC) and bone mineral density (BMD) in same side hip, according to a study published in the March issue of the Journal of Craniofacial Surgery.

Abstract
Full Text

Copyright © 2011 ScoutNews, LLC. All rights reserved.


Previous: April 2011 Briefing - Pulmonology Next: April 2011 Briefing - Surgery

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.